InSite reports second quarter net income of $12.1 million

After a loss of $6.8 million in the second quarter of 2012, InSite Vision has reported a net income of $12.1 million for the second quarter of 2013, according to a company news release.The increase is largely attributable to InSite’s sale of royalty rights to Besivance (besifloxacin ophthalmic suspension 0.6%) for $15 million.

Full Story →